Vascular remodeling and protease inhibition - Bench to bedside

Cardiovascular Research

Volumn 69, Issue 3, 2006, Pages 595-603

  Sluijter, Joost P G ^a,b   De Kleijn, Dominique P V ^a,b   Pasterkamp, Gerard ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

Author keywords

Atherosclerosis; Matrix metalloproteinases (MMP); MMP inhibition; Vascular remodeling

Indexed keywords

COLLAGEN; ELASTIN; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE INHIBITOR; TISSUE INHIBITOR OF METALLOPROTEINASE;

ANEURYSM; ATHEROSCLEROSIS; BALLOON DILATATION; BLOOD FLOW; EXTRACELLULAR MATRIX; HEART VENTRICLE REMODELING; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEINASE INHIBITION; RESTENOSIS; REVIEW; VASCULAR DISEASE;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; CORONARY DISEASE; CORONARY RESTENOSIS; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MATRIX METALLOPROTEINASES; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 31344462860     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2005.11.026     Document Type: Review

References (98)

1. J.F.J. Woessner Matrix metalloproteinases and their inhibitors in connective tissue remodeling FASEB J 5 1991 2145 2154
2. H. Nagase Activation mechanisms of matrix metalloproteinases Biol Chem 378 1997 151 160
3. Z.S. Galis, G.K. Sukhova, M.W. Lark, and P. Libby Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques J Clin Invest 94 1994 2493 2503
4. S.C. Tyagi, L. Meyer, R.A. Schmaltz, H.K. Reddy, and D.J. Voelker Proteinases and restenosis in the human coronary artery: extracellular matrix production exceeds the expression of proteolytic activity Atherosclerosis 116 1995 43 57
5. S.C. Tyagi, S.E. Campbell, H.K. Reddy, E. Tjahja, and D.J. Voelker Matrix metalloproteinase activity expression in infarcted, noninfarcted and dilated cardiomyopathic human hearts Mol Cell Biochem 155 1996 13 21
6. J.P. Cleutjens, J.C. Kandala, E. Guarda, R.V. Guntaka, and K.T. Weber Regulation of collagen degradation in the rat myocardium after infarction J Mol Cell Cardiol 27 1995 1281 1292
7. G.H. Gibbons, and V.J. Dzau The emerging concept of vascular remodeling N Engl J Med 330 1994 1431 1438
8. P. Libby, P.M. Ridker, and A. Maseri Inflammation and atherosclerosis Circulation 105 2002 1135 1143
9. R. Ross Atherosclerosis-an inflammatory disease N Engl J Med 340 1999 115 126
10. P.K. Shah, E. Falk, J.J. Badimon, A. Fernandez-Ortiz, A. Mailhac, and G. Villareal-Levy Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metalloproteinases and implications for plaque rupture Circulation 92 1995 1565 1569
11. S. Glagov, E. Weisenberg, C.K. Zarins, R. Stankunavicius, and G.J. Kolettis Compensatory enlargement of human atherosclerotic coronary arteries N Engl J Med 316 1987 1371 1375
12. N.J. Weissman, S.J. Sheris, R. Chari, F.O. Mendelsohn, W.D. Anderson, and J.A. Breall Intravascular ultrasonic analysis of plaque characteristics associated with coronary artery remodeling Am J Cardiol 84 1999 37 40
13. R.T. Fuessl, E. Kranenberg, U. Kiausch, F.M. Baer, U. Sechtem, and H.W. Hopp Vascular remodeling in atherosclerotic coronary arteries is affected by plaque composition Coron Artery Dis 12 2001 91 97
14. G. Pasterkamp, A.H. Schoneveld, D.J. Hijnen, D.P. de Kleijn, H. Teepen, and A.C. van der Wal Atherosclerotic arterial remodeling and the localization of macrophages and matrix metalloproteases 1, 2 and 9 in the human coronary artery Atherosclerosis 150 2000 245 253
15. G.K. Sukhova, U. Schonbeck, E. Rabkin, F.J. Schoen, A.R. Poole, and R.C. Billinghurst Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques Circulation 99 1999 2503 2509
16. M.J. Post, C. Borst, and R.E. Kuntz The relative importance of arterial remodeling compared with intimal hyperplasia in lumen renarrowing after balloon angioplasty. A study in the normal rabbit and the hypercholesterolemic Yucatan micropig Circulation 89 6 1994 (Jun.) 2816 2821
17. E.E. Creemers, J.P. Cleutjens, J.F. Smits, and M.J. Daemen Matrix metalloproteinase inhibition after myocardial infarction: a new approach to prevent heart failure? Circ Res 89 2001 201 210
18. A.H. Baker, D.R. Edwards, and G. Murphy Metalloproteinase inhibitors: biological actions and therapeutic opportunities J Cell Sci 115 2002 3719 3727
19. Z.S. Galis, G.K. Sukhova, and P. Libby Microscopic localization of active proteases by in situ zymography: detection of matrix metalloproteinase activity in vascular tissue FASEB J 9 1995 974 980
20. Z.S. Galis, G.K. Sukhova, R. Kranzhofer, S. Clark, and P. Libby Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases Proc Natl Acad Sci U S A 92 1995 402 406
21. A.B. Zaltsman, and A.C. Newby Increased secretion of gelatinases A and B from the aortas of cholesterol fed rabbits: relationship to lesion severity Atherosclerosis 130 1997 61 70
22. A.C. Newby Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture Physiol Rev 85 2005 1 31
23. B.W. Wang, H. Chang, S. Lin, P. Kuan, and K.G. Shyu Induction of matrix metalloproteinases-14 and -2 by cyclical mechanical stretch is mediated by tumor necrosis factor-alpha in cultured human umbilical vein endothelial cells Cardiovasc Res 59 2003 460 469
24. S.C. Tyagi, K. Lewis, D. Pikes, A. Marcello, V.S. Mujumdar, and L.M. Smiley Stretch-induced membrane type matrix metalloproteinase and tissue plasminogen activator in cardiac fibroblast cells J Cell Physiol 176 1998 374 382
25. S. Rajagopalan, X.P. Meng, S. Ramasamy, D.G. Harrison, and Z.S. Galis Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability J Clin Invest 98 1996 2572 2579
26. B.L. Langille, and F. O'Donnell Reductions in arterial diameter produced by chronic decreases in blood flow are endothelium-dependent Science 231 1986 405 407
27. J.K. Karwowski, A. Markezich, J. Whitson, T.A. Abbruzzese, C.K. Zarins, and R.L. Dalman Dose-dependent limitation of arterial enlargement by the matrix metalloproteinase inhibitor RS-113,456 J Surg Res 87 1999 122 129
28. F. Tronc, Z. Mallat, S. Lehoux, M. Wassef, B. Esposito, and A. Tedgui Role of matrix metalloproteinases in blood flow-induced arterial enlargement: interaction with NO Arterioscler Thromb Vasc Biol 20 2000 E120 E126
29. D.P. de Kleijn, J.P. Sluijter, J. Smit, E. Velema, W. Richard, and A.H. Schoneveld Furin and membrane type-1 metalloproteinase mRNA levels and activation of metalloproteinase-2 are associated with arterial remodeling FEBS Lett 501 2001 37 41
30. T.A. Abbruzzese, R.J. Guzman, R.L. Martin, C. Yee, C.K. Zarins, and R.L. Dalman Matrix metalloproteinase inhibition limits arterial enlargements in a rodent arteriovenous fistula model Surgery 124 1998 328 334
31. N. Zempo, N. Koyama, R.D. Kenagy, H.J. Lea, and A.W. Clowes Regulation of vascular smooth muscle cell migration and proliferation in vitro and in injured rat arteries by a synthetic matrix metalloproteinase inhibitor Arterioscler Thromb Vasc Biol 16 1996 28 33
32. M.P. Bendeck, N. Zempo, A.W. Clowes, R.E. Galardy, and M.A. Reidy Smooth muscle cell migration and matrix metalloproteinase expression after arterial injury in the rat Circ Res 75 1994 539 545
33. M.P. Bendeck, C. Irvin, and M.A. Reidy Inhibition of matrix metalloproteinase activity inhibits smooth muscle cell migration but not neointimal thickening after arterial injury Circ Res 78 1996 38 43
34. M.F. Prescott, W.K. Sawyer, J. Von Linden-Reed, M. Jeune, M. Chou, and S.L. Caplan Effect of matrix metalloproteinase inhibition on progression of atherosclerosis and aneurysm in LDL receptor-deficient mice overexpressing MMP-3, MMP-12, and MMP-13 and on restenosis in rats after balloon injury Ann N Y Acad Sci 878 1999 179 190
35. B.J. de Smet, D. de Kleijn, R. Hanemaaijer, J.H. Verheijen, L. Robertus, and Y.J. van Der Helm Metalloproteinase inhibition reduces constrictive arterial remodeling after balloon angioplasty: a study in the atherosclerotic Yucatan micropig Circulation 101 2000 2962 2967
36. M.J. Sierevogel, G. Pasterkamp, E. Velema, P.P. de Jaegere, B.J. de Smet, and J.H. Verheijen Oral matrix metalloproteinase inhibition and arterial remodeling after balloon dilation: an intravascular ultrasound study in the pig Circulation 103 2001 302 307
37. M.J. Sierevogel, E. Velema, F.J. van der Meer, M.O. Nijhuis, M. Smeets, and D.P. de Kleijn Matrix metalloproteinase inhibition reduces adventitial thickening and collagen accumulation following balloon dilation Cardiovasc Res 55 2002 864 869
38. Z.S. Galis, C. Johnson, D. Godin, R. Magid, J.M. Shipley, and R.M. Senior Targeted disruption of the matrix metalloproteinase-9 gene impairs smooth muscle cell migration and geometrical arterial remodeling Circ Res 91 2002 852 859
39. M.J. Sierevogel, E. Velema, P.P. de Jaegere, D.P. de Kleijn, C. Borst, and G. Pasterkamp Minimal duration of oral matrix metalloproteinase inhibition to prevent constrictive arterial remodeling after balloon dilation in the pig Radiology 222 2002 468 473
40. M.P. Bendeck, M. Conte, M. Zhang, N. Nili, B.H. Strauss, and S.M. Farwell Doxycycline modulates smooth muscle cell growth, migration, and matrix remodeling after arterial injury Am J Pathol 160 2002 1089 1095
41. L.J. Feldman, M. Mazighi, A. Scheuble, J.F. Deux, E. De Benedetti, and C. Badier-Commander Differential expression of matrix metalloproteinases after stent implantation and balloon angioplasty in the hypercholesterolemic rabbit Circulation 103 2001 3117 3122
42. C. Li, W.J. Cantor, N. Nili, R. Robinson, L. Fenkell, Y.L. Tran, and H.A. Whittingham Arterial repair after stenting and the effects of GM6001, a matrix metalloproteinase inhibitor J Am Coll Cardiol 39 2002 1852 1858
43. M.J. Sierevogel, E. Velema, A.H. Schoneveld, D.P.V. de Kleijn, C. Borst, and G. Pasterkamp The effect of collagen turnover modulation on in-stent restenosis: a study in the atherosclerotic and the non-atherosclerotic Yucatan minipig Circulation 106 2002 [II-715-II-715.Abstract]
44. H.M. van Beusekom, M.J. Post, D.M. Whelan, B.J. de Smet, D.J. Duncker, and W.J. van der Giessen Metalloproteinase inhibition by Batimastat does not reduce neointimal thickening in stented atherosclerotic porcine femoral arteries Cardiovasc Radiat Med 4 2003 186 191
45. G.S. Cherr, S.J. Motew, J.A. Travis, J. Fingerle, L. Fisher, and M. Brandl Metalloproteinase (MMP) inhibition and restenosis following angioplasty and stenting in atherosclerotic nonhuman primates Arterioscler Thromb Vasc Biol 22 2002 161 166
46. J.E. Sousa, P.W. Serruys, and M.A. Costa New frontiers in cardiology drug-eluting stents: Part II Circulation 107 2003 2383
47. G. Moore, S. Liao, J.A. Curci, B.C. Starcher, R.L. Martin, and R.T. Hendricks Suppression of experimental abdominal aortic aneurysms by systemic treatment with a hydroxamate-based matrix metalloproteinase inhibitor (RS 132908) J Vasc Surg 29 1999 522 532
48. D.A. Bigatel, J.R. Elmore, D.J. Carey, G. Cizmeci-Smith, D.P. Franklin, and J.R. Youkey The matrix metalloproteinase inhibitor BB-94 limits expansion of experimental abdominal aortic aneurysms J Vasc Surg 29 1999 130 138
49. D. Petrinec, S. Liao, D.R. Holmes, J.M. Reilly, W.C. Parks, and R.W. Thompson Doxycycline inhibition of aneurysmal degeneration in an elastase-induced rat model of abdominal aortic aneurysm: preservation of aortic elastin associated with suppressed production of 92 kD gelatinase J Vasc Surg 23 1996 336 346
50. J.A. Curci, D. Petrinec, S. Liao, L.M. Golub, and R.W. Thompson Pharmacologic suppression of experimental abdominal aortic aneurysms: a comparison of doxycycline and four chemically modified tetracyclines J Vasc Surg 28 1998 1082 1093
51. J.A. Curci, D. Mao, D.G. Bohner, B.T. Allen, B.G. Rubin, and J.M. Reilly Preoperative treatment with doxycycline reduces aortic wall expression and activation of matrix metalloproteinases in patients with abdominal aortic aneurysms J Vasc Surg 31 2000 325 342
52. M. Mosorin, J. Juvonen, F. Biancari, J. Satta, H.M. Surcel, and M. Leinonen Use of doxycycline to decrease the growth rate of abdominal aortic aneurysms: a randomized, double-blind, placebo-controlled pilot study J Vasc Surg 34 2001 606 610
53. B. Axisa, I.M. Loftus, A.R. Naylor, S. Goodall, L. Jones, and P.R. Bell Prospective, randomized, double-blind trial investigating the effect of doxycycline on matrix metalloproteinase expression within atherosclerotic carotid plaques Stroke 33 2002 2858 2864
54. D.L. Brown, K.K. Desai, B.A. Vakili, C. Nouneh, H.M. Lee, and L.M. Golub Clinical and biochemical results of the metalloproteinase inhibition with subantimicrobial doses of doxycycline to prevent acute coronary syndromes (MIDAS) pilot trial Arterioscler Thromb Vasc Biol 24 2004 733 738
55. S.A. Berceli, Z. Jiang, N.V. Klingman, C.L. Pfahnl, Z.S. Abouhamze, and C.D. Frase Differential expression and activity of matrix metalloproteinases during flow-modulated vein graft remodeling J Vasc Surg 39 2004 1084 1090
56. J.I. Rotmans, E. Velema, H.J. Verhagen, J.D. Blankensteijn, D.P. de Kleijn, and E.S. Stroes Matrix metalloproteinase inhibition reduces intimal hyperplasia in a porcine arteriovenous-graft model J Vasc Surg 39 2004 432 439
57. Z. Luan, A.J. Chase, and A.C. Newby Statins inhibit secretion of metalloproteinases-1,-2,-3, and -9 from vascular smooth muscle cells and macrophages Arterioscler Thromb Vasc Biol 23 2003 769 775
58. M. Aikawa, E. Rabkin, Y. Okada, S.J. Voglic, S.K. Clinton, and C.E. Brinckerhoff Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabbit atheroma: a potential mechanism of lesion stabilization Circulation 97 1998 2433 2444
59. M. Aikawa, E. Rabkin, S.J. Voglic, H. Shing, R. Nagai, and F.J. Schoen Lipid lowering promotes accumulation of mature smooth muscle cells expressing smooth muscle myosin heavy chain isoforms in rabbit atheroma Circ Res 83 1998 1015 1026
60. E.F. Steinmetz, C. Buckley, M.L. Shames, T.L. Ennis, S.J. Vanvickle-Chavez, and D. Mao Treatment with simvastatin suppresses the development of experimental abdominal aortic aneurysms in normal and hypercholesterolemic mice Ann Surg 241 2005 92 101
61. G.K. Sukhova, J.K. Williams, and P. Libby Statins reduce inflammation in atheroma of nonhuman primates independent of effects on serum cholesterol Arterioscler Thromb Vasc Biol 22 2002 1452 1458
62. K.K. Koh, J.W. Son, J.Y. Ahn, D.K. Jin, H.S. Kim, and Y.M. Choi Comparative effects of diet and statin on NO bioactivity and matrix metalloproteinases in hypercholesterolemic patients with coronary artery disease Arterioscler Thromb Vasc Biol 22 2002 e19 e23
63. M. Crisby, G. Nordin-Fredriksson, P.K. Shah, J. Yano, J. Zhu, and J. Nilsson Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization Circulation 103 2001 926 933
64. P.K. Henke, S. Blackburn, M.C. Proctor, J. Stevens, D. Mukherjee, and S. Rajagopalin Patients undergoing infrainguinal bypass to treat atherosclerotic vascular disease are underprescribed cardioprotective medications: effect on graft patency, limb salvage, and mortality J Vasc Surg 39 2004 357 365
65. R. Hoekstra, F.A. Eskens, and J. Verweij Matrix metalloproteinase inhibitors: current developments and future perspectives Oncologist 6 2001 415 427
66. B. De, M.G. Natchus, M. Cheng, S. Pikul, N.G. Almstead, and Y.O. Taiwo The next generation of MMP inhibitors. Design and synthesis Ann N Y Acad Sci 878 1999 40 60
67. R. Forough, N. Koyama, D. Hasenstab, H. Lea, M. Clowes, and S.T. Nikkari Overexpression of tissue inhibitor of matrix metalloproteinase-1 inhibits vascular smooth muscle cell functions in vitro and in vivo Circ Res 79 1996 812 820
68. C.M. Dollery, S.E. Humphries, A. McClelland, D.S. Latchman, and J.R. McEwan Expression of tissue inhibitor of matrix metalloproteinases 1 by use of an adenoviral vector inhibits smooth muscle cell migration and reduces neointimal hyperplasia in the rat model of vascular balloon injury Circulation 99 1999 3199 3205
69. S.J. George, A.H. Baker, G.D. Angelini, and A.C. Newby Gene transfer of tissue inhibitor of metalloproteinase-2 inhibits metalloproteinase activity and neointima formation in human saphenous veins Gene Ther 5 1998 1552 1560
70. L. Cheng, G. Mantile, R. Pauly, C. Nater, A. Felici, and R. Monticone Adenovirus-mediated gene transfer of the human tissue inhibitor of metalloproteinase-2 blocks vascular smooth muscle cell invasiveness in vitro and modulates neointimal development in vivo Circulation 98 1998 2195 2201
71. S.J. George, C.T. Lloyd, G.D. Angelini, A.C. Newby, and A.H. Baker Inhibition of late vein graft neointima formation in human and porcine models by adenovirus-mediated overexpression of tissue inhibitor of metalloproteinase-3 Circulation 2000 296 304
72. Y.H. Guo, W. Gao, Q. Li, P.F. Li, P.Y. Yao, and K. Chen Tissue inhibitor of metalloproteinases-4 suppresses vascular smooth muscle cell migration and induces cell apoptosis Life Sci 75 2004 2483 2493
73. C. Furman, Z. Luo, K. Walsh, N. Duverger, C. Copin, and J.C. Fruchart Systemic tissue inhibitor of metalloproteinase-1 gene delivery reduces neointimal hyperplasia in balloon-injured rat carotid artery FEBS Lett 531 2002 122 126
74. M.L. Lamfers, J.M. Grimbergen, M.C. Aalders, M.J. Havenga, M.R. de Vries, and L.G. Huisman Gene transfer of the urokinase-type plasminogen activator receptor-targeted matrix metalloproteinase inhibitor TIMP-1.ATF suppresses neointima formation more efficiently than tissue inhibitor of metalloproteinase-1 Circ Res 91 2002 945 952
75. S.S. Lakka, C.S. Gondi, D.H. Dinh, W.C. Olivero, M. Gujrati, and V.H. Rao Specific interference of urokinase-type plasminogen activator and matrix metalloproteinase-9 gene expression induced by double-stranded RNA results in decreased invasion, tumor growth and angiogenesis in gliomasi J Biol Chem 280 2005 21882 21892
76. P. Hamar, E. Song, G. Kokeny, A. Chen, N. Ouyang, and J. Lieberman Small interfering RNA targeting Fas protects mice against renal ischemia-reperfusion injury Proc Natl Acad Sci U S A 101 2004 14883 14888
77. T.C. Major, L. Liang, X. Lu, W. Rosebury, and T.M. Bocan Extracellular matrix metalloproteinase inducer (EMMPRIN) is induced upon monocyte differentiation and is expressed in human atheroma Arterioscler Thromb Vasc Biol 22 2002 1200 1207
78. H. Guo, S. Zucker, M.K. Gordon, B.P. Toole, and C. Biswas Stimulation of matrix metalloproteinase production by recombinant extracellular matrix metalloproteinase inducer from transfected Chinese hamster ovary cells J Biol Chem 272 1997 24 27
79. J. Oh, R. Takahashi, S. Kondo, A. Mizoguchi, E. Adachi, and R.M. Sasahara The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis Cell 107 2001 789 800
80. P. Stawowy, H. Meyborg, D. Stibenz, N.B. Stawowy, M. Roser, and U. Thanabalasingam Furin-like proprotein convertases are central regulators of the membrane type matrix metalloproteinase-pro-matrix metalloproteinase-2 proteolytic cascade in atherosclerosis Circulation 111 2005 2820 2827
81. J.P. Sluijter, R.E. Verloop, W.P. Pulskens, E. Velema, J.M. Grimbergen, and P.H. Quax Involvement of furin-like proprotein convertases in the arterial response to injury Cardiovasc Res 68 2005 136 143
82. M.C. Moon, K. Molnar, L. Yau, and P. Zahradka Perivascular delivery of losartan with surgical fibrin glue prevents neointimal hyperplasia after arterial injury J Vasc Surg 40 2004 130 137
83. F. Cipollone, M. Fazia, A. Iezzi, B. Pini, C. Cuccurullo, and M. Zucchelli Blockade of the angiotensin II type 1 receptor stabilizes atherosclerotic plaques in humans by inhibiting prostaglandin E2-dependent matrix metalloproteinase activity Circulation 109 2004 1482 1488
84. A.W. Barolet, N. Nili, A. Cheema, R. Robinson, M.K. Natarajan, and S. O'Blenes Arterial elastase activity after balloon angioplasty and effects of elafin, an elastase inhibitor Arterioscler Thromb Vasc Biol 21 2001 1269 1274
85. N. Nili, A.N. Cheema, F.J. Giordano, A.W. Barolet, S. Babaei, and R. Hickey Decorin inhibition of PDGF-stimulated vascular smooth muscle cell function: potential mechanism for inhibition of intimal hyperplasia after balloon angioplasty Am J Pathol 163 2003 869 878
86. M.J. Goumans, F. Lebrin, and G. Valdimarsdottir Controlling the angiogenic switch: a balance between two distinct TGF-b receptor signaling pathways Trends Cardiovasc Med 13 2003 301 307
87. J. El Bedoui, M.H. Oak, P. Anglard, and V.B. Schini-Kerth Catechins prevent vascular smooth muscle cell invasion by inhibiting MT1-MMP activity and MMP-2 expression Cardiovasc Res 67 2005 317 325
88. M.H. Oak, J. El Bedoui, P. Anglard, and V.B. Schini-Kerth Red wine polyphenolic compounds strongly inhibit pro-matrix metalloproteinase-2 expression and its activation in response to thrombin via direct inhibition of membrane type 1-matrix metalloproteinase in vascular smooth muscle cells Circulation 110 2004 1861 1867
89. M. Kuzuya, S. Kanda, T. Sasaki, N. Tamaya-Mori, X.W. Cheng, and T. Itoh Deficiency of gelatinase a suppresses smooth muscle cell invasion and development of experimental intimal hyperplasia Circulation 108 2003 1375 1381
90. A. Cho, and M.A. Reidy Matrix metalloproteinase-9 is necessary for the regulation of smooth muscle cell replication and migration after arterial injury Circ Res 91 2002 845 851
91. C. Johnson, and Z.S. Galis Matrix metalloproteinase-2 and -9 differentially regulate smooth muscle cell migration and cell-mediated collagen organization Arterioscler Thromb Vasc Biol 24 2004 54 60
92. D.P. Mason, R.D. Kenagy, D. Hasenstab, D.F. Bowen-Pope, R.A. Seifert, and S. Coats Matrix metalloproteinase-9 overexpression enhances vascular smooth muscle cell migration and alters remodeling in the injured rat carotid artery Circ Res 85 1999 1179 1185
93. H.R. Lijnen, B. Van Hoef, I. Vanlinthout, M. Verstreken, M.C. Rio, and D. Collen Accelerated neointima formation after vascular injury in mice with stromelysin-3 (MMP-11) gene inactivation Arterioscler Thromb Vasc Biol 19 1999 2863 2870
94. J. Silence, F. Lupu, D. Collen, and H.R. Lijnen Persistence of atherosclerotic plaque but reduced aneurysm formation in mice with stromelysin-1 (MMP-3) gene inactivation Arterioscler Thromb Vasc Biol 21 2001 1440 1445
95. V. Lemaitre, T.K. O'Byrne, A.C. Borczuk, Y. Okada, A.R. Tall, and J. D'Armiento ApoE knockout mice expressing human matrix metalloproteinase-1 in macrophages have less advanced atherosclerosis J Clin Invest 107 2001 1227 1234
96. J. Silence, D. Collen, and H.R. Lijnen Reduced atherosclerotic plaque but enhanced aneurysm formation in mice with inactivation of the tissue inhibitor of metalloproteinase-1 (TIMP-1) gene Circ Res 90 20023 897 903
97. V. Lemaitre, P.D. Soloway, and J. D'Armiento Increased medial degradation with pseudo-aneurysm formation in apolipoprotein E-knockout mice deficient in tissue inhibitor of metalloproteinases-1 Circulation 107 2003 333 338
98. A. Luttun, E. Lutgens, A. Manderveld, K. Maris, D. Collen, and P. Carmeliet Loss of matrix metalloproteinase-9 or matrix metalloproteinase-12 protects apolipoprotein E-deficient mice against atherosclerotic media destruction but differentially affects plaque growth Circulation 109 2004 1408 1414